Braidwell »

PerkinElmer shares owned by Braidwell

Quarter-by-quarter ownership of PerkinElmer (RVTY) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in PerkinElmer

Tip: Access up to 7 years of quarterly data

All positions including PerkinElmer held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in PerkinElmer by Braidwell

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.2M 48k 87.61

More positions owned by Braidwell

Caris Life Sciences (CAI)
Guardant Health Debt 1.250% 2/1 (Principal)
Repligen Corp Note 1.000%12/1 (Principal)
Neogenomics Note 0.250% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Glaukos (GKOS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Xenon Pharmaceuticals (XENE)
Dianthus Therapeutics (DNTH)
Edgewise Therapeutics (EWTX)
Irhythm Technologies (IRTC)
Nuvalent Inc-a (NUVL)
Kodiak Sciences (KOD)
Cg Oncology (CGON)
Alphatec Hldgs Note 0.750% 3/1 (Principal)

View all positions for Braidwell

Top funds holding PerkinElmer

T. Rowe Price Investment Management
Vanguard Group
Edgepoint Investment
Henderson Group
Vanguard Capital Management
BlackRock
Vanguard Portfolio Management
State Street Corporation
Geode Capital Management
Dimensional Fund Advisors
Invesco
Morgan Stanley
Allspring Global Investments Holdings
RGM Capital
UBS Group

View all funds holding PerkinElmer